In this report we demonstrate that metformin-sensitive breast cancer cells arrest in G0/G1 due to activation of AMPK, downregulation of cyclin D1, and enhanced binding of CDK2 by p27Kip1 and p21Cip1. Here, CDK2 is linked to breast carcinoma.